Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respira
about
Clinical review: severe asthma.Approach to Patients with Severe Asthma: a Consensus Statement from the Respiratory Care Experts' Input Forum (RC-EIF), IranChildhood asthma: diagnosis and treatmentDual oxidase regulates neutrophil recruitment in allergic airwaysHow variability in clinical phenotypes should guide research into disease mechanisms in asthmaRestoration of corticosteroid sensitivity by p38 mitogen activated protein kinase inhibition in peripheral blood mononuclear cells from severe asthmaUnrecognised psychopathology in patients with difficult asthma: major mental and personality disorders.Qualitative analysis of high-resolution CT scans in severe asthmaBone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma.Canadian Thoracic Society Asthma Management Continuum--2010 Consensus Summary for children six years of age and over, and adults.Impaired macrophage phagocytosis of bacteria in severe asthma.Thiazolidinediones and the risk of asthma exacerbation among patients with diabetes: a cohort study.Testing bias in clinical databases: methodological considerations.Difficult-to-control asthma management through the use of a specific protocolMulti-symptom asthma is closely related to nasal blockage, rhinorrhea and symptoms of chronic rhinosinusitis-evidence from the West Sweden Asthma Study.MicroRNA-146a and microRNA-146b expression and anti-inflammatory function in human airway smooth muscle.Blood neutrophil activation markers in severe asthma: lack of inhibition by prednisolone therapyRecommendation for optimal management of severe refractory asthma.Difficult asthma in children.Development of a novel severe triple allergen asthma model in mice which is resistant to dexamethasone and partially resistant to TLR7 and TLR9 agonist treatment.Treatment compliance, passive smoking, and asthma control: a three year cohort studyOxidants induce a corticosteroid-insensitive phosphorylation of histone 3 at serine 10 in monocytes.Predictors of therapy resistant asthma: outcome of a systematic evaluation protocolCombination of lung ultrasound (a comet-tail sign) and N-terminal pro-brain natriuretic peptide in differentiating acute heart failure from chronic obstructive pulmonary disease and asthma as cause of acute dyspnea in prehospital emergency settingBET bromodomains regulate transforming growth factor-β-induced proliferation and cytokine release in asthmatic airway smooth muscle.Clinical asthma phenotyping: A trial for bridging gaps in asthma managementST13 polymorphisms and their effect on exacerbations in steroid-treated asthmatic children and young adults.Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma.Bacteria in sputum of stable severe asthma and increased airway wall thicknessA cross-sectional study evaluating the relationship between cortisol suppression and asthma control in patients with difficult asthma.Steroid response in refractory asthmaticsAsthma Economic Costs in Adult Asthmatic Patients in Tehran, Iran.Relationship between serum vitamin D, disease severity, and airway remodeling in children with asthma.Enterococcus faecalis overcomes foreign body-mediated inflammation to establish urinary tract infections.Inhaled and systemic corticosteroid response in severe asthma assessed by alveolar nitric oxide: a randomized crossover pilot study of add-on therapy.Adjusted subpixel method enables optimisation of bronchial measurements in high-resolution CT.Lack of autophagy induces steroid-resistant airway inflammation.Severe asthma: an expanding and mounting clinical challenge.Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma.Serum interleukins 6 and 8 in mild and severe asthmatic patients, is it difference?
P2860
Q24537771-70A2E27E-AEA2-4DFE-B61C-18CAF34CF8F5Q26777154-9D0536E9-1238-4C4D-8A4A-AD3F7A00B024Q26863351-971FCA66-DA3D-436F-9942-A98184DE2574Q28588484-969603A7-A0D8-45F3-9CD9-8E5A65EEA901Q28657369-4E9AC1BB-2A5F-4B56-99BF-7C283AECE97EQ28728945-2FE496D3-F577-4030-B956-BEFA682F5C73Q30489960-147781DC-A8A0-4B9B-9E9C-2446C0B63E7BQ33632072-5114DD49-281F-4977-92EE-C45A846B7030Q33777681-2D2FDA52-03D6-46A4-A349-C8D6470A3F0DQ33836132-AC39F308-960F-46D4-A840-8EB25AA3A9AEQ33864335-C0FB758F-D2BF-4759-93FF-DFF52E45BA2BQ33891499-32785EA1-68DE-49E4-961A-5A848E9491EDQ33912082-020371EA-5457-4985-8499-220A755F8E74Q34197997-BE33C796-5B17-4724-8BDC-47FCED10E089Q34419181-C2007531-0083-43D5-8C5A-FC7ED60036FFQ34439903-548F2FA1-9BCD-4739-BF03-8D918FFC1D91Q34594817-43A68BF0-472D-4376-ADB8-4585D85794EEQ34620187-40BD6680-D694-41CC-B779-04803BE8E7E4Q34905952-B65754CC-90C5-49D6-BD41-BA4B0AF3D951Q35117670-B0AC6263-A351-41E8-A645-C5C11BE1A440Q35275503-D9509E83-FB8D-4E61-89DA-3BBF61408C5FQ35532441-E8D43AEE-8A25-4D57-A4B9-E7CB39D18739Q35536031-46CC05E4-3CC5-42AB-9880-70D1192C919DQ35559614-CB4F31D4-DAA8-4C4C-A0C6-C5A33030914DQ35580851-3BAE33E8-78F8-4BEA-947B-535047E059ABQ35626634-C74B6B4C-9938-4862-83F3-C9F9AEBC1976Q35707632-67D9F314-35CD-4460-973E-B97CD3524DFBQ35890173-8DF81660-1687-475C-A0E8-F054B873DF32Q35955401-BBCB1D3C-066B-467C-9BBA-BC7FBD2B93ACQ36024948-4787DD30-5E14-40F5-96F3-BFBFE70BB69DQ36025200-714211AB-837C-4B25-9862-979B0AB43EE2Q36282175-7C4BB46A-AF83-4D6C-8756-1E0BB5A33F13Q36316785-D88E213D-4DF3-42B7-9474-3E6F56B51087Q36506189-26BA4049-28B7-44B8-B393-D18786CB8E44Q36562454-23835AAB-F89A-4187-8B28-65AF2D745031Q36653251-2BE7A95A-37CE-44E6-BB19-C2EE2C13F657Q36880440-DC11A722-88CF-4785-A4DB-8D72ED4D0117Q36935177-21E8C773-9C45-4D94-9BC0-690D35F3307FQ37144279-FEE0AFE4-D190-46B7-B02D-C19B9ECC95CAQ37155808-089A24CF-FE3A-41C9-8F46-48411C27C185
P2860
Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respira
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Difficult/therapy-resistant as ...... stant Asthma. European Respira
@ast
Difficult/therapy-resistant as ...... stant Asthma. European Respira
@en
type
label
Difficult/therapy-resistant as ...... stant Asthma. European Respira
@ast
Difficult/therapy-resistant as ...... stant Asthma. European Respira
@en
prefLabel
Difficult/therapy-resistant as ...... stant Asthma. European Respira
@ast
Difficult/therapy-resistant as ...... stant Asthma. European Respira
@en
P2093
P1476
Difficult/therapy-resistant as ...... stant Asthma. European Respira
@en
P2093
C Corrigan
C G Lofdahl
E Adelroth
H Kerstjens
H Magnussen
P304
P577
1999-05-01T00:00:00Z